Pearl has today (17 March) announced plans to expand access to its Practice Intelligence® AI solution for customers in Europe. The company’s international footprint is growing rapidly––spurred by accelerating global adoption of its flagship Second Opinion® real-time pathology detection software and a series of recent global integration and distribution partnerships. A spokesperson explains.
Pearl announced its expansion plans during the 2023 International Dental Show (IDS) in Cologne, Germany, where the company and several partners are showcasing the company’s FDA-cleared AI technology. Designed to optimise dental practice operations, elevate clinical performance, and grow production, Practice Intelligence synthesises actionable insights from AI-powered evaluation of x-rays and analysis of treatment data across a practice’s entire patient population.
The AI platform treats those insights with a suite of morning huddle, recall, referral, and performance-analytics reporting utilities developed to serve clinical providers, front-office staff, managers, and owners.
Dr Kyle Stanley, Chief Clinical Officer at Pearl, said: “Practice Intelligence delivers unrivalled insights into population-wide patient health and treatment trends, accuracy of clinical findings, and optimised workflows.
“Expanding support for Practice Intelligence to Europe will give European dentists the benefits of the most complete clinical AI toolset in dentistry and is a testament to Pearl’s commitment to accelerating the global adoption of AI-backed dental care.”
Pearl paved the way for AI technology in dentistry with the launch of its Second Opinion clinical radiology solution at IDS 2021. As the first and most comprehensive AI-powered real-time pathology detection aid for dentists, Second Opinion has received international regulatory clearances for clinical deployment in numerous countries around the world, including the United States, Canada, Australia, New Zealand, United Arab Emirates, Saudi Arabia, Brazil, and Israel, where it has been adopted by thousands of dental practices and DSOs.
Pearl is supporting its growth in Europe with the help of a number of established and soon-to-be-announced software integration and distribution partners, including Planmeca and 3M.
Ophir Tanz, CEO and Founder of Pearl, added: “Pearl’s expansion in Europe will ensure that the rate of AI adoption among dentists around the world continues to climb. In bringing the full breadth of AI’s capabilities and benefits to more dental practices around the world, we proudly continue to serve our mission of revolutionising the standard of dental care on a global scale.”
To learn more about Pearl’s AI solutions, go to https://www.hellopearl.com/products/practice-intelligence, or visit one of the following exhibit stands at IDS until 18th March:
Pearl – Hall 4.1, Stand E-50
3M – 4.2, Stand G-90
Planmeca – Hall 1, Stand A20–C29
See the original article here: Dental Industry Review